echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Cell Rep Med: Reactogenicity of Multiple COVID-19 Vaccination Regimens and Immunogenicity to Omicron Cell Press Paper Express

    Cell Rep Med: Reactogenicity of Multiple COVID-19 Vaccination Regimens and Immunogenicity to Omicron Cell Press Paper Express

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    medicine

    Medicine

    The rapid development of a highly effective vaccine against SARS-CoV-2 is one of the greatest scientific achievements of the contemporary world



    Argentina currently uses multiple vaccines against SARS-CoV-2, including the non-replicating adenovirus vaccine Sputnik V (Gamaleya Institute), ChAdOx1-S (Oxford-AstraZeneca) and Ad5-nCoV (CanSino); the mRNA vaccine BNT162b2 (Pfizer) and mRNA-1273 (Moderna); and the SARS-CoV-2 vaccine BBIBP-CorV (Sinopharm, Sinopharm) using an inactivated virus



    This study showed that various heterologous vaccination regimens induced higher antibody responses than those induced by homologous regimens


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.